Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-03-05 @ 1:33 AM
Study NCT ID:
NCT03357159
Status:
UNKNOWN
Last Update Posted:
2023-11-28
First Post:
2017-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation
Sponsor:
Sheba Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
SHEBA-17-4055-AN-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None